Julie Beck
Analyst · Deutsche Bank. Please go ahead. Your line is open
Thanks, John, and good morning, everyone. Let's take a look at our third quarter financial performance filed on Slide 12. We demonstrated solid execution in a dynamic environment, including significant supply chain challenges and continued inflation. Sales of $1.1 billion were up 13% year-over-year on higher volume and improved price realization necessary to mitigate rising costs. Sales in constant currency were up 21% as foreign currency translation negatively impacted sales by $78 million or approximately 8% in the quarter as the euro and British pound weakened against the dollar. Gross margins increased by 320 basis points in the quarter as volume, pricing, favorable mix and cost-out initiatives helped to offset cost increases and the negative impact of foreign exchange rates. The year-over-year gross margin increase was in both our segments with steady sequential improvement in AWP. MP continued to effectively overcome cost increases with pricing actions. SG&A was in line with expectations, but up over the prior year as a result of inflation, incremental spend due to acquisitions and prudent investments in technology and new product development. SG& A was 10.4% of sales and decreased by 10 basis points from the prior year, with business investment offset by continued strict expense management. Income from operations of $121 million was up 63% year-over-year. We were pleased to report an operating margin of 10.8%, up 330 basis points compared to the prior year and up 120 basis points sequentially. Our incremental margins were 37% compared to the prior year and 39% from the second quarter. Current quarter operating profit includes restructuring charges of $1 million in AWP associated with our Oklahoma City facility. Interest and other expense of $13 million was comparable with Q3 of 2021. The third quarter global effective tax rate was approximately 24% and A higher tax rate is primarily due to increased tax on the geographic distribution of income, partially offset by lower U.S. tax on foreign income. Third quarter earnings per share of $1.20 increased 79%, representing a $0.53 improvement over last year. This strong performance driven by volume, price and disciplined cost control also reflects an unfavorable earnings per share impact of $0.14 from foreign exchange translation. Our return on invested capital of 19% significantly exceeded our cost of capital as we continue to invest in the business and return cash to shareholders through dividends and share repurchases. Free cash flow for the quarter of $53 million demonstrated continued sequential quarterly improvement in results. I will discuss free cash flow later in more detail. Let's look at our segment results. Starting with our Materials Processing segment found on Slide 13. MP sales of $458 million increased 9% compared to the third quarter of 2021 with healthy demand for our products across multiple businesses. On a foreign exchange neutral basis, sales were up 20%. The business ended the quarter with a total backlog of $1.2 billion, up 14% from a year ago. The strong backlog level supports our sales outlook and is approximately 3x historical norms. In these challenging markets, MP increased our operating profit to 14.6% and continued their excellent operational execution. MP has been able to demonstrate strong performance in this inflationary environment with a 25% incremental margin over the prior year. On Slide 14, see our Aerial Work Platforms segment financial results. AWP had an excellent quarter with sales of $663 million, up 16% compared to the prior year on price realization and higher demand. On a foreign exchange neutral basis, sales increased 22%. Total backlog at quarter end was $2.7 billion, up 44% from the prior year. Both GE and utilities have taken multiple price actions over the course of 2021 and 2022 to address inflationary cost pressures. In addition, both businesses have been battling part shortages, constraining their growth. AWP delivered operating margin of 9.6% in the quarter, up 350 basis points from last year and up 190 basis points sequentially from the second quarter of 2022. This year-over-year and sequential improvement was a result of higher sales volumes, favorable mix, cost reduction initiatives, strict expense management and disciplined pricing actions. Included in AWP earnings for the quarter was a reclassification from corporate and other of $5.2 million related to prior period transactional foreign exchange losses. Absent this charge, Q3 operating margins were 10.4%. Please see Slide 15 for an overview of our disciplined capital allocation strategy. Free cash flow for the quarter was $53 million, consistent with our sequential improvement goals, but below our expectations as inventory levels remain high in the third quarter. Hospital inventory in the third quarter was $63 million, consistent with the second quarter. Now let me detail our capital deployment in the quarter. We continue to invest in our business with capital expenditures, acquisitions and technology investments of $74 million. A large portion of our capital expenditures is related to our Monterrey, Mexico facility, which remains on schedule and budget. We had $42 million of investments primarily associated with ProAll and Acculon announced in August. Returning cash to shareholders is an important element of our disciplined capital allocation strategy. The company continued its quarterly dividend per share of $0.13, an 8. 3% increase over the prior year. We also repurchased $13 million of shares in the quarter. Given our operating performance and long-term growth prospects, we believe Terex shares are an attractive investment. We have $47 million remaining on our share repurchase program. The company's strong balance sheet has allowed us to return approximately $120 million of cash to shareholders year-to-date. We have significantly delevered over the past four years and strengthened our balance sheet. Outstanding gross debt has been reduced by $349 million since the third quarter of 2019, a 30% decrease and $67 million since the third quarter of 2021 or a 7.5% decrease. We have no near-term maturities until 2024, and 72% of our debt is at a fixed rate of 5% until the end of the decade. Our net leverage remains low at 1.4x, which is well below our 2.5x target through the cycle. We have ample liquidity of $658 million. The company is in an excellent position to run and grow the business. Now turning to Slide 16 and our full year outlook. Thanks to the strong execution of our team members and our robust backlog, we are raising our 2022 outlook to the upper end of our prior range. We now expect earnings per share of $4 to $4.20. This outlook incorporates an additional unfavorable $0.05 per share due to foreign exchange from our prior outlook. Overall, we anticipate a full year negative FX impact of approximately $0. 45 per share versus the prior year. Supply chain challenges, inflation pressures, geopolitical uncertainty and volatile foreign currency markets continue, and our team has successfully navigated these challenges for three quarters of 2022. We expect continued strong execution for the remainder of the year. Our strong backlog supports our sales outlook, which we have now increased to approximately $4.3 billion. Sales are not a function of demand, but rather the ability of the supply chain to deliver components. We have the internal capacity to produce more, which we have demonstrated in the past. For the full year, our sales growth is based on improved price execution of approximately 10%, volume growth of 7%, partially offset by unfavorable foreign exchange of 6%. SG&A cost management has been excellent, and we maintain our full year outlook of 10.6% of sales. Our operating margin outlook has been updated to approximately 9. 5%, which was at the upper end of our prior range. We estimate a share count of approximately $69.5 million based on repurchase activities in the current year. We are reaffirming our full year effective tax rate of 20%. While we expect sequential free cash flow improvement in the fourth quarter, we now expect full year free cash flow of approximately $125 million. This is primarily a result of higher inventory levels due to the supply chain disruption and negative foreign exchange. Corporate & Other has been reduced to $73 million. We expect our incremental margins in the fourth quarter to be above our 25% target. Turning to the segment outlook. Based upon MP's successful mitigation of persistent input costs, supply chain challenges and strong performance to date, we expect net sales of approximately $1.9 billion with an operating margin range of 15% to 15.3%. Supply chain challenges continue to be disruptive in the AWP segment. However, the team has made progress on deliveries, and we expect net sales of approximately $2.4 billion. Incorporating the team's cost out and expense management initiatives, we are estimating a full year operating margin of approximately 8%. This segment has been negatively impacted by the strengthening of the U. S. dollar to the euro and the British pound. We continue to expect to be price/cost neutral for the full year. We are pleased to raise our earnings per share outlook to a range of $4 to $4.20. And with that, I will turn it back to you, John.